312 related articles for article (PubMed ID: 20607622)
21. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
Dhib-Jalbut S
Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
[TBL] [Abstract][Full Text] [Related]
22. Sphingolipids in psychiatric disorders and pain syndromes.
Mühle C; Reichel M; Gulbins E; Kornhuber J
Handb Exp Pharmacol; 2013; (216):431-56. PubMed ID: 23563670
[TBL] [Abstract][Full Text] [Related]
23. Roles for C16-ceramide and sphingosine 1-phosphate in regulating hepatocyte apoptosis in response to tumor necrosis factor-alpha.
Osawa Y; Uchinami H; Bielawski J; Schwabe RF; Hannun YA; Brenner DA
J Biol Chem; 2005 Jul; 280(30):27879-87. PubMed ID: 15946935
[TBL] [Abstract][Full Text] [Related]
24. Influence of sphingolipids on T lymphocyte activation.
Martinova EA
Biochemistry (Mosc); 1998 Jan; 63(1):102-10. PubMed ID: 9526101
[TBL] [Abstract][Full Text] [Related]
25. Advances in the signal transduction of ceramide and related sphingolipids.
Liu G; Kleine L; Hébert RL
Crit Rev Clin Lab Sci; 1999 Dec; 36(6):511-73. PubMed ID: 10656539
[TBL] [Abstract][Full Text] [Related]
26. Sphingolipid metabolism, oxidant signaling, and contractile function of skeletal muscle.
Nikolova-Karakashian MN; Reid MB
Antioxid Redox Signal; 2011 Nov; 15(9):2501-17. PubMed ID: 21453197
[TBL] [Abstract][Full Text] [Related]
27. Novelty of Sphingolipids in the Central Nervous System Physiology and Disease: Focusing on the Sphingolipid Hypothesis of Neuroinflammation and Neurodegeneration.
Ayub M; Jin HK; Bae JS
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34298977
[TBL] [Abstract][Full Text] [Related]
28. Role of bioactive sphingolipids in physiology and pathology.
Gomez-Larrauri A; Presa N; Dominguez-Herrera A; Ouro A; Trueba M; Gomez-Muñoz A
Essays Biochem; 2020 Sep; 64(3):579-589. PubMed ID: 32579188
[TBL] [Abstract][Full Text] [Related]
29. Oligodendrocyte-specific FADD deletion protects mice from autoimmune-mediated demyelination.
Mc Guire C; Volckaert T; Wolke U; Sze M; de Rycke R; Waisman A; Prinz M; Beyaert R; Pasparakis M; van Loo G
J Immunol; 2010 Dec; 185(12):7646-53. PubMed ID: 21068410
[TBL] [Abstract][Full Text] [Related]
30. Ceramide and Sphingosine Regulation of Myelinogenesis: Targeting Serine Palmitoyltransferase Using microRNA in Multiple Sclerosis.
Dasgupta S; Ray SK
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614447
[TBL] [Abstract][Full Text] [Related]
31. Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance.
Ponnusamy S; Meyers-Needham M; Senkal CE; Saddoughi SA; Sentelle D; Selvam SP; Salas A; Ogretmen B
Future Oncol; 2010 Oct; 6(10):1603-24. PubMed ID: 21062159
[TBL] [Abstract][Full Text] [Related]
32. [The role of sphingolipids in selected cardiovascular diseases].
Kurek K; Piotrowska DM; Wiesiołek-Kurek P; Chabowska A; Łukaszuk B; Żendzian-Piotrowska M
Postepy Hig Med Dosw (Online); 2013 Sep; 67():1018-26. PubMed ID: 24088546
[TBL] [Abstract][Full Text] [Related]
33. Sphingosine kinase signalling in immune cells: potential as novel therapeutic targets.
Melendez AJ
Biochim Biophys Acta; 2008 Jan; 1784(1):66-75. PubMed ID: 17913601
[TBL] [Abstract][Full Text] [Related]
34. Regulating survival and development in the retina: key roles for simple sphingolipids.
Rotstein NP; Miranda GE; Abrahan CE; German OL
J Lipid Res; 2010 Jun; 51(6):1247-62. PubMed ID: 20100817
[TBL] [Abstract][Full Text] [Related]
35. Contrasting potential of nitric oxide and peroxynitrite to mediate oligodendrocyte injury in multiple sclerosis.
Jack C; Antel J; Brück W; Kuhlmann T
Glia; 2007 Jul; 55(9):926-34. PubMed ID: 17437305
[TBL] [Abstract][Full Text] [Related]
36. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids.
Hannun YA; Linardic CM
Biochim Biophys Acta; 1993 Dec; 1154(3-4):223-36. PubMed ID: 8280742
[TBL] [Abstract][Full Text] [Related]
37. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of neutrophil apoptosis via sphingolipid signaling in acute lung injury.
Lin WC; Lin CF; Chen CL; Chen CW; Lin YS
J Pharmacol Exp Ther; 2011 Oct; 339(1):45-53. PubMed ID: 21724966
[TBL] [Abstract][Full Text] [Related]
39. Cancer treatment strategies targeting sphingolipid metabolism.
Oskouian B; Saba JD
Adv Exp Med Biol; 2010; 688():185-205. PubMed ID: 20919655
[TBL] [Abstract][Full Text] [Related]
40. Nudging oligodendrocyte intrinsic signaling to remyelinate and repair: Estrogen receptor ligand effects.
Khalaj AJ; Hasselmann J; Augello C; Moore S; Tiwari-Woodruff SK
J Steroid Biochem Mol Biol; 2016 Jun; 160():43-52. PubMed ID: 26776441
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
